A Fungicide Innovation Addressing Resistance Management for European Farmers
BEIJING and TEL AVIV, Israel, May 6, 2025 — ADAMA Ltd. (SZSE: 000553), a prominent global crop protection firm, today announced that its innovative Active Ingredient Gilboa
has been recognized by the Fungicide Resistance Action Committee (FRAC) as possessing a unique mode of action in cereal crops.
Gilboa acts on nucleic acid metabolism within Group 32, a biochemical pathway not previously targeted by cereal fungicides, marking a substantial advancement. This offers significant protection against major cereal and oilseed rape diseases like Septoria and Sclerotinia, equipping European farmers with a robust tool for managing resistance.
“Gilboa signifies a significant advancement in fungicide technology, providing farmers with a completely new method for controlling fungal pathogens in cereals,” stated Florian Wagner, EVP Portfolio and Innovation at ADAMA. “Its unique mode of action, combined with its compatibility with current fungicides, positions it as a crucial component of disease management strategies.”
Fungal diseases, such as Septoria, have shown increasing resistance to existing chemical solutions over time, diminishing their effectiveness. Gilboa’s innovative mechanism provides farmers with a much-needed alternative, helping to safeguard yields and protect crops from developing threats.
“Gilboa is a transformative solution for European farmers, offering a breakthrough in sustainable disease management,” said Alex Mills, Head of Global Fungicides at ADAMA. “Its novel mode of action, which targets nucleic acid metabolism, is vital because recent major launches in Cereal Fungicides are mainly following the same modes of action i.e. QoI’s and SDHI’s. By broadening the options available to farmers, Gilboa supports reliable, long-term disease control while lowering the risk of resistance. This empowers farmers with more effective strategies to protect their crops and yields in the long run.”
Gilboa, the trade name for flumetylsulforim, an imino-tosyl-pyrimidinone chemistry, has been classified as Group 32 by FRAC. Since its initial development, ADAMA has performed numerous trials, which have consistently yielded excellent results.
In trials for Septoria in wheat, a notable percentage displayed superior results compared to existing solutions. Furthermore, Gilboa provided extended disease control, with effects lasting up to 35 days after the final application. Trials also indicated that over 70% of the flag leaf area remained green for a longer duration post-treatment, leading to increased yields.
Gilboa was submitted for registration in 2023 and is anticipated to be approved in Great Britain in 2027 and in the EU in 2029, with additional registrations planned for other regions. Field demonstrations will be held in the UK during June 2025, enabling customers to observe Gilboa’s technical performance firsthand.
About ADAMA
ADAMA Ltd. is a global leader in crop protection, delivering effective solutions to farmers worldwide to combat weeds, insects, and diseases. Our culture encourages ADAMA’s employees to actively engage with farmers and innovate from practical experience. ADAMA’s broad portfolio of existing active ingredients, combined with its advanced formulation capabilities and proprietary formulation technology platforms, uniquely positions the company to develop high-quality, innovative, and sustainable products that address the many challenges faced by farmers and customers today. ADAMA serves customers in over 100 countries. For more information, visit us at .
ADAMA Contact:
Tal Moise
Public Relations
Email:
Logo:
SOURCE Adama Agricultural Solutions Ltd